Cargando…

Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes

Detalles Bibliográficos
Autores principales: Foer, Dinah, Beeler, Patrick E., Cui, Jing, Karlson, Elizabeth W., Bates, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017586/
https://www.ncbi.nlm.nih.gov/pubmed/33508207
http://dx.doi.org/10.1164/rccm.202012-4511LE
_version_ 1783674079504498688
author Foer, Dinah
Beeler, Patrick E.
Cui, Jing
Karlson, Elizabeth W.
Bates, David W.
author_facet Foer, Dinah
Beeler, Patrick E.
Cui, Jing
Karlson, Elizabeth W.
Bates, David W.
author_sort Foer, Dinah
collection PubMed
description
format Online
Article
Text
id pubmed-8017586
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-80175862021-04-02 Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes Foer, Dinah Beeler, Patrick E. Cui, Jing Karlson, Elizabeth W. Bates, David W. Am J Respir Crit Care Med Correspondence American Thoracic Society 2021-04-01 2021-04-01 /pmc/articles/PMC8017586/ /pubmed/33508207 http://dx.doi.org/10.1164/rccm.202012-4511LE Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Foer, Dinah
Beeler, Patrick E.
Cui, Jing
Karlson, Elizabeth W.
Bates, David W.
Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
title Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
title_full Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
title_fullStr Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
title_full_unstemmed Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
title_short Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
title_sort reply to watchorn et al.: asthma exacerbations in individuals on glucagon-like peptide-1 receptor agonists for type 2 diabetes
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017586/
https://www.ncbi.nlm.nih.gov/pubmed/33508207
http://dx.doi.org/10.1164/rccm.202012-4511LE
work_keys_str_mv AT foerdinah replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes
AT beelerpatricke replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes
AT cuijing replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes
AT karlsonelizabethw replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes
AT batesdavidw replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes